Music & MEmory: A Pragmatic TRial for Nursing Home Residents With ALzheimer's Disease (METRIcAL)_part2 (METRIcAL)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04850807 |
|
Recruitment Status :
Enrolling by invitation
First Posted : April 20, 2021
Last Update Posted : January 21, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Dementia | Behavioral: Music & Memory | Not Applicable |
The purpose of this study is to conduct a parallel, pragmatic, cluster randomized control trial of personalized music (Music and Memory) for nursing home residents with moderate to severe dementia living in 54 nursing homes (27 treatment, 27 control) from 4 nursing home corporations. Music and Memory is a personalized music program that uses portable music players to deliver individualized music to people with dementia at times when agitated behaviors are likely.
**This funding mechanism sponsored two parallel trials with different implementation strategies. In this trial, music is preloaded on personalized music devices to increase nursing use of the music with residents. Details of the first parallel trial conducted under this funding mechanism are registered under "R33AG057451_part1."**
The aims of this study are: 1. To use a train-the-trainer model to implement the intervention with ongoing monitoring of the program's adoption and acceptance by nursing home residents with dementia; 2. To estimate the impact of Music and Memory on agitated and aggressive behaviors; and 3. To examine factors associated with variation in providers' adherence to the implementation of Music and Memory.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 810 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | The investigator's primary outcome (staff report of resident agitated and aggressive behaviors) will be evaluated using a parallel design |
| Masking: | Single (Investigator) |
| Masking Description: | Principal investigator is blinded to allocation of nursing homes to treatment or control conditions |
| Primary Purpose: | Supportive Care |
| Official Title: | Music & MEmory: A Pragmatic TRial for Nursing Home Residents With ALzheimer's Disease |
| Actual Study Start Date : | May 1, 2021 |
| Estimated Primary Completion Date : | March 1, 2022 |
| Estimated Study Completion Date : | May 31, 2022 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: Usual Care
Usual care for managing agitated and/or aggressive behaviors in the nursing home setting
|
|
|
Experimental: Music & Memory
Music and Memory is a personalized music program in which nursing home staff provide people with dementia with music playlists tailored to their personal history of music preferences at early signs of agitation
|
Behavioral: Music & Memory
Music and Memory is a personalized music program in which caregivers (nursing home staff, family, or others) provide people with dementia with music playlists tailored to their personal history of music preferences at times when behaviors are likely |
- Frequency of agitated and aggressive behaviors (staff report) [ Time Frame: 8-months ]The tool used to interview staff about resident behaviors is the Cohen-Mansfield Agitation Inventory (CMAI). Research staff interview nursing staff who knows the resident well to ask how frequently 29 agitated/aggressive behaviors occurred in the past week. There are seven response choices for each item, anchored from never (1) to several times per hour (7). Total scores on the CMAI range from 29 to 203, with higher scores representing more frequent agitated/aggressive behaviors. The CMAI is administered at three points in time: baseline, 4 months, and 8 months. The minimum of the 4- and 8-month scores will be the study outcome for intervention and control participants. The minimum observed frequency of agitated and aggressive behaviors after intended exposure to the intervention (treatment) or after 8-months (control), conditional upon survival to at least one post-intervention observation (up to 4 months after baseline measurement).
- Frequency of agitated and aggressive behaviors (administrative data) [ Time Frame: 8 months ]The Aggressive Behavior Scale is a 4 item measure describing the frequency of physical behavioral symptoms directed toward others; verbal behavioral symptoms directed toward others; other behavioral symptoms not directed toward others; and behaviors related to resisting necessary care. For each item, frequency in the past week is reported as: behavior not exhibited (0); behavior occurred 1-3 days (1); behavior occurred 4-6 days (2); or behavior occurred daily (3). The Aggressive Behavior Scale ranges from 0 to 12, with higher scores indicating more frequent agitated and/or aggressive behaviors. Mean total scores will be compared for treatment and control populations.
- Antipsychotic use [ Time Frame: 8 months ]Any antipsychotic use in the past week and days of use in the past week, based on Minimum Data Set (standardized assessment of nursing home residents). Comparison of percent with any use and mean days will be compared for treatment and control populations
- Antianxietal use [ Time Frame: 8 months ]Any antianxietal use in the past week and days of use in the past week, based on Minimum Data Set (standardized assessment of nursing home residents). Comparison of percent with any use and mean days will be compared for treatment and control populations
- Antidepressant use [ Time Frame: 8 months ]Any antidepressant use in the past week and days of use in the past week, based on Minimum Data Set (standardized assessment of nursing home residents). Comparison of percent with any use and mean days will be compared for treatment and control populations
- Hypnotic use [ Time Frame: 8 months ]Any hypnotic use in the past week and days of use in the past week, based on Minimum Data Set (standardized assessment of nursing home residents). Comparison of percent with any use and mean days for treatment and control populations, before and after implementation
- Depression [ Time Frame: 8 months ]The Patient Health Questionnaire is a 9-item screening assessment for depression severity. For each item, respondents indicate the frequency of the symptom in the past 2 weeks using the following choices: never or one day (0); 2-6 days (1); 7-11 days (2); or 12-14 days (3). Total scores range from 0 to 27, with higher scores indicating more frequent depressive symptoms. Average total scores will be compared for treatment and control populations.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria for Nursing Homes:
- Owned by partnering health care corporations
- Medicare / Medicaid-certified
- Have at least 20 eligible residents
Inclusion Criteria for Residents in Eligible Nursing Homes
- Reside in eligible nursing home for last 90 days
- Have a dementia diagnosis
Exclusion Criteria for Nursing Homes:
- recent situations that may affect implementation (for example, bad state or federal quality assurance surveys, leadership turnover, or other competing demands)
- previous use of Music and Memory
Exclusion Criteria for Residents in Eligible Nursing Homes:
- dislikes music
- completely deaf
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04850807
| United States, Georgia | |
| PruittHealth | |
| Norcross, Georgia, United States, 30093 | |
| United States, Nebraska | |
| Vetter Senior Living | |
| Elkhorn, Nebraska, United States, 68022 | |
| United States, Ohio | |
| CommuniCare Terrapins Division | |
| Blue Ash, Ohio, United States, 45241 | |
| United States, South Dakota | |
| Good Samaritan Society | |
| Sioux Falls, South Dakota, United States, 57108 | |
| Principal Investigator: | Vincent Mor, PHD | Brown University, School of Public Health |
| Responsible Party: | Vincent Mor, Florence Pirce Grant University Professor, Professor of Health Services, Policy and Practice, Brown University |
| ClinicalTrials.gov Identifier: | NCT04850807 |
| Other Study ID Numbers: |
R33AG057451_part2 R33AG057451 ( U.S. NIH Grant/Contract ) |
| First Posted: | April 20, 2021 Key Record Dates |
| Last Update Posted: | January 21, 2022 |
| Last Verified: | January 2022 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Tauopathies Neurodegenerative Diseases Neurocognitive Disorders Mental Disorders |

